1Schuetz EG,Beck WT,Schuetz JD.Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells[J].Mol Pharmacol,1996,49:311. 被引量：1
2Hustert E,Haberl M,Burk O,et al.The genetic determinants of the CYP-3A5 polymorphism[J].Pharmacogenetics,2001,11(9):773. 被引量：1
3Wojnowski L.Genetics of the variable expression of CYP3A in humans[J].Ther Drug Monit,2004,26(2):192. 被引量：1
4Burk O,Wojnowski L.Cytochrome P450 3A and their regulation[J].Naunyn Schmiedebergs Arch Pharmacol,2004,369(1):105. 被引量：1
6Silvestri L,Sonzogni L,De Silvestri A,et al.CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer[J].Int J Cancer,2003,104(3):310. 被引量：1
7Chowbay B,Zhou S,Lee EJ.An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters:experience in Singapore[J].Drug Metab Rev,2005,37(2):327. 被引量：1
8Lamba JK,Lin YS,Schuetz EG,et al.Genetic contribution to variable human CYP3A-mediated metabolism[J].Adv Drug Deliv Rev,2002,54(10):1271. 被引量：1
9Schuetz EG.Lessons from the CYP3A4 promoter[J].Mol Pharmacol,2004,65(2):279. 被引量：1
10Wang H,Xie J,Zhang Z,et al.Study on polymorphisms of CYP3A5 gene and their clinical role[J].Zhonghua Yi Xue Yi Chuan Xue Za Zhi,2005,22(4):423. 被引量：1
